Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Chandra A, Dhar P, Dharap S, Goel A, Gupta R, Hardikar JV, Kapoor VK, Mathur AK, Modi P, Narwaria M, Ramesh MK, Ramesh H, Sastry RA, Shah S, Virk S, Sudheer OV, Sreevathsa MR, Varshney S, Kochhar P, Somasundaram S, Desai C, Schou M. Chandra A, et al. Among authors: ramesh mk, ramesh h. Surg Infect (Larchmt). 2008 Jun;9(3):367-76. doi: 10.1089/sur.2007.013. Surg Infect (Larchmt). 2008. PMID: 18570578 Clinical Trial.
Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
Lucasti C, Popescu I, Ramesh MK, Lipka J, Sable C. Lucasti C, et al. Among authors: ramesh mk. J Antimicrob Chemother. 2013 May;68(5):1183-92. doi: 10.1093/jac/dks523. Epub 2013 Feb 7. J Antimicrob Chemother. 2013. PMID: 23391714 Clinical Trial.
Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infections.
Solomkin JS, Ramesh MK, Cesnauskas G, Novikovs N, Stefanova P, Sutcliffe JA, Walpole SM, Horn PT. Solomkin JS, et al. Among authors: ramesh mk. Antimicrob Agents Chemother. 2014;58(4):1847-54. doi: 10.1128/AAC.01614-13. Epub 2013 Dec 16. Antimicrob Agents Chemother. 2014. PMID: 24342651 Free PMC article. Clinical Trial.
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, Hoste E, Levy H, Hirman J, Levi M, Daga M, Kutsogiannis DJ, Crowther M, Bernard GR, Devriendt J, Puigserver JV, Blanzaco DU, Esmon CT, Parrillo JE, Guzzi L, Henderson SJ, Pothirat C, Mehta P, Fareed J, Talwar D, Tsuruta K, Gorelick KJ, Osawa Y, Kaul I. Vincent JL, et al. Among authors: ramesh mk. Crit Care Med. 2013 Sep;41(9):2069-79. doi: 10.1097/CCM.0b013e31828e9b03. Crit Care Med. 2013. PMID: 23979365 Clinical Trial.
Tuberculosis biliary stricture simulating as cholangiocarcinoma.
Padhiari RK, Ramesh MK, G P P, Ahmed N. Padhiari RK, et al. Among authors: ramesh mk. J Clin Diagn Res. 2015 Mar;9(3):PL01-2. doi: 10.7860/JCDR/2015/11266.5706. Epub 2015 Mar 1. J Clin Diagn Res. 2015. PMID: 25954666 Free PMC article. No abstract available.
35 results